Revolutionizing Immunotherapy Discovery with the Power of AI
We are pioneering a new era of immunotherapy design and development by leveraging the convergence of artificial intelligence and advanced biological modeling. Protein Design Technology is uniquely positioned to transform drug discovery by dramatically reducing the timeline from concept to clinic - from more than a decade to just months. By computationally reconstructing key aspects of human T-cell immunity, we are unlocking unprecedented speed and precision in therapeutic development.
Our Mission
Our mission is to build a comprehensive, AI-driven platform that enables the rapid identification and optimization of personalized T-cell therapies. By applying patient-specific data with our proprietary computational models and clinically proven T-cell engineering platform, we aim to deliver tailored treatments that precisely target individual cancer profiles.
Reconstructing Human T Cell Immunity on a Chip
Our Approach
We believe the key to enabling rapid and efficient generation of therapeutic solutions for a wide range of diseases in the age of AI is to establish a comprehensive digital library of the human immune system.
Identifying Cancer-Related Targets
T cells, the main warriors of immune cells, protect your body by recognizing and eliminating pathogen-presenting cells in a standardized modular manner. This unique mechanism allows researchers to explore between 10,000 and 100,000 potential cancer-related targets. By constructing detailed digital representations of T-cell behavior and antigen recognition, we can rapidly explore vast target landscapes.
Deploying the Power of AI in Drug Candidate Discovery
Once these antigen targets are identified and recorded digitally, we employ advanced computational modeling to simulate and analyze the intricate interactions within the human immune system. Our proprietary algorithms trained by the comprehensive digital library of immunological data are capable of significantly accelerating the discovery and development of an ideal matching binder for each given target.
Developing Personalized T-cell Therapies for Every Cancer Patient
A 'Plug-and-Play' Approach to Personalized T-cell Therapy to Treat and Cure Cancer
Our integrated platform seamlessly translates AI-identified targets into T-cell therapies with a clinically proven T-cell engineering system that enables the rapid deployment of personalized treatments.
By matching optimized binders to individual patient's antigen profiles and applying them to our proprietary T-cell platform, we create highly specific, safe and effective immunotherapy candidates. This 'plug-and-play' approach accelerates the delivery of truly tailored T-cell treatments that are designed to treat a particular patient’s specific tumor, maximizing therapeutics impact in the fight for a cure.
